Risk of epilepsy in rheumatoid arthritis: a meta-analysis of population based studies and bioinformatics analysis
Risk of epilepsy in rheumatoid arthritis: a meta-analysis of population based studies and bioinformatics analysis
复制标题
类风湿性关节炎的癫痫风险:基于人群的研究和生物信息学分析的荟萃分析
DOI:
10.1177/2040622319899300
复制
发表时间:
2020-01
影响因子:
3.5
通讯作者:
Xu Zhenghao
中科院分区:
文献类型:
--
作者:
Zhao Huawei;Li Shan;Xie Meijuan;Chen Rongrong;Lu Haimei;Wen Chengping;Filiano Anthony J.;Xu Zhenghao
Background: An increasing number of studies support an association between rheumatoid arthritis (RA) and brain disorders. This study aims to determine the association between RA and epilepsy. Methods: A comprehensive search of databases in both English and Chinese was performed. Data from the selected studies were extracted and analyzed independently by two authors. Genes associated with epilepsy and RA were also collected and analyzed. Results: We included six nationwide population based studies (n = 7,094,113 cases in total) for the meta-analysis. The risk of epilepsy was increased in RA patients [risk ratio (RR) = 1.601; 95% confidence interval (CI): 1.089–2.354; p = 0.017; n = 3,803,535 cases] and children born to mothers with RA (RR = 1.475; 95% CI: 1.333–1.633; p < 0.001, n = 3,290,578 cases). Subgroup analysis and meta-regression showed the RR of epilepsy in RA was negatively correlated with age. Furthermore, we found that 433 identified genes in a coexpression network from the hippocampi of 129 epileptic patients were enriched in the RA and related Kyoto Encyclopedia of Genes and Genomes pathways, while 13 genes (mainly related to inflammatory cytokines and chemokines) were identified as potential key genes bridging the RA and epilepsy. Conclusions: Our study, utilizing meta-analysis and bioinformatical data, highlights a close association between epilepsy and RA. Further studies are still warranted to expand these findings, especially for a population that is exposed to RA during fetal and childhood periods.
登录
查看更多内容
影响因子:
15.8
作者:
Moher D;Liberati A;Tetzlaff J;Altman DG;PRISMA Group
通讯作者:
PRISMA Group
影响因子:
5.1
作者:
Weyand CM;Yang Z;Goronzy JJ
通讯作者:
Goronzy JJ
DOI:
10.1136/bmj.b2535
发表时间:
2009-07-21
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Moher D;Liberati A;Tetzlaff J;Altman DG;PRISMA Group
通讯作者:
PRISMA Group
影响因子:
1.6
作者:
Chang KH;Hsu YC;Chang MY;Lin CL;Wu TN;Hwang BF;Chen CY;Liu HC;Kao CH
通讯作者:
Kao CH
影响因子:
3.3
作者:
T. Nishioku;K. Furusho;A. Tomita;H. Ohishi;S. Dohgu;H. Shuto;A. Yamauchi;Y. Kataoka
通讯作者:
T. Nishioku;K. Furusho;A. Tomita;H. Ohishi;S. Dohgu;H. Shuto;A. Yamauchi;Y. Kataoka